468 related articles for article (PubMed ID: 30602058)
1. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.
Erstad DJ; Chiang YJ; Witt RG; Cope B; Nassif EF; Scally CP; Torres KE; Feig BW; Hunt KK; Bishop AJ; Guadagnolo BA; Roland CL; Keung EZ
Ann Surg Oncol; 2023 Feb; 30(2):926-940. PubMed ID: 36115928
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results.
Callegaro D; Raut CP; Ajayi T; Strauss D; Bonvalot S; Ng D; Stoeckle E; Fairweather M; Rutkowski P; van Houdt WJ; Gelderblom H; Sangalli C; Hayes A; Honoré C; Gladdy RA; Fau M; Haas R; Tzanis D; Miah AB; Chung P; Baldini EH; Marreaud S; Litiere S; Swallow CJ; Gronchi A
Ann Surg; 2023 Jul; 278(1):127-134. PubMed ID: 35833413
[TBL] [Abstract][Full Text] [Related]
4. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
[TBL] [Abstract][Full Text] [Related]
7. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database.
Nussbaum DP; Rushing CN; Lane WO; Cardona DM; Kirsch DG; Peterson BL; Blazer DG
Lancet Oncol; 2016 Jul; 17(7):966-975. PubMed ID: 27210906
[TBL] [Abstract][Full Text] [Related]
8. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
[TBL] [Abstract][Full Text] [Related]
9. Preoperative radiotherapy in the management of retroperitoneal liposarcoma.
Ecker BL; Peters MG; McMillan MT; Sinnamon AJ; Zhang PJ; Fraker DL; Levin WP; Roses RE; Karakousis GC
Br J Surg; 2016 Dec; 103(13):1839-1846. PubMed ID: 27682864
[TBL] [Abstract][Full Text] [Related]
10. Influence of age and subtype in outcome of operable liposarcoma.
Greto D; Saieva C; Loi M; Terziani F; Visani L; Garlatti P; Lo Russo M; Muntoni C; Becherini C; Topulli J; Campanacci D; Beltrami G; Scoccianti G; Muratori F; Bonomo P; Desideri I; Francolini G; Livi L
Radiol Med; 2019 Apr; 124(4):290-300. PubMed ID: 30421387
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
13. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
14. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
15. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.
Nassif EF; Cope B; Traweek R; Witt RG; Erstad DJ; Scally CP; Thirasastr P; Zarzour MA; Ludwig J; Benjamin R; Bishop AJ; Guadagnolo BA; Ingram D; Wani K; Wang WL; Lazar AJ; Torres KE; Hunt KK; Feig BW; Roland CL; Somaiah N; Keung EZ
Int J Cancer; 2022 Jun; 150(12):2012-2024. PubMed ID: 35128664
[TBL] [Abstract][Full Text] [Related]
16. The role of standard and novel radiotherapy approaches in management of retroperitoneal sarcomas.
Wiltink LM; Spalek MJ; Sangalli C; Haas RL
Eur J Surg Oncol; 2023 Jun; 49(6):1111-1114. PubMed ID: 36115783
[TBL] [Abstract][Full Text] [Related]
17. What Are the Results of Resection of Localized Dedifferentiated Liposarcomas in the Extremities?
Nakata E; Kunisada T; Hasei J; Nakahara R; Yanai H; Toji T; Inoue Ct H; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2550-2561. PubMed ID: 33112583
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
Jour G; Gullet A; Liu M; Hoch BL
Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
[TBL] [Abstract][Full Text] [Related]
19. Low and moderate grade retroperitoneal liposarcoma: Is adjuvant radiotherapy associated with improved survival in patients undergoing R1 resection?
Littau MJ; Bunn C; Kim P; Kulshrestha S; Tonelli C; Abdelsattar ZM; Luchette FA; Baker MS
Am J Surg; 2022 Mar; 223(3):527-530. PubMed ID: 34974888
[TBL] [Abstract][Full Text] [Related]
20. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
Gronchi A; Miceli R; Allard MA; Callegaro D; Le Péchoux C; Fiore M; Honoré C; Sanfilippo R; Coppola S; Stacchiotti S; Terrier P; Casali PG; Le Cesne A; Mariani L; Colombo C; Bonvalot S
Ann Surg Oncol; 2015 May; 22(5):1447-54. PubMed ID: 25300609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
